Is RVVTF or NNN a better dividend investment in 2026?

RVVTF currently yields 7692.31% with a 5% 5-year dividend growth rate. NNN yields 5.66% with 2.8% growth. The better choice depends on your goal: RVVTF offers higher current income.

What is the dividend yield difference between RVVTF and NNN?

RVVTF has a forward dividend yield of 7692.31% ($2.00/share annually). NNN yields 5.66% ($2.38/share annually). The yield gap is 7686.65 percentage points.

Home › Compare › RVVTF vs NNN

RVVTF vs NNN: Dividend Comparison 2026

RVVTF yields 7692.31% · NNN yields 5.66%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RVVTF wins by $4177739098279589.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

RVVTF

● Live price

7692.31%

Share price

$0.03

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4177739098279589.00M

Annual income

$4,073,565,928,588,968,500,000.00

Full RVVTF calculator →

NNN

NNN REIT Inc.

● Live price

5.66%

Share price

$42.03

Annual div

$2.38

5Y div CAGR

8.6%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.5K

Annual income

$2,622.67

Full NNN calculator →

Portfolio growth — RVVTF vs NNN

📍 RVVTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	RVVTF	NNN
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, RVVTF + NNN cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

RVVTF pays

NNN pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RVVTF

Annual income on $10K today (after 15% tax)

$653,846.15/yr

After 10yr DRIP, annual income (after tax)

$3,462,531,039,300,623,000,000.00/yr

NNN

Annual income on $10K today (after 15% tax)

$481.32/yr

After 10yr DRIP, annual income (after tax)

$2,229.27/yr

At 15% tax rate, RVVTF beats the other by $3,462,531,039,300,623,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RVVTF + NNN for your $10,000?

RVVTF: 50%NNN: 50%

100% NNN50/50100% RVVTF

Portfolio after 10yr

$2088869549139794.50M

Annual income

$2,036,782,964,294,484,200,000.00/yr

Blended yield

97.51%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

RVVTF

No analyst data

Altman Z

-566.5

Piotroski

1/9

NNN

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$44.93

+6.9% upside vs current

Range: $43.00 — $48.50

Altman Z

1.1

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RVVTF buys

NNN buys

No recent congressional trades found for RVVTF or NNN in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricRVVTFNNN

Forward yield	7692.31% ✓	5.66%
Annual dividend / share	$2.00	$2.38 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	8.6% ✓
Portfolio after 10y	$4177739098279589.00M ✓	$25.5K
Annual income after 10y	$4,073,565,928,588,968,500,000.00 ✓	$2,622.67
Total dividends collected	$4170772265337663.00M ✓	$13.7K
Payment frequency	quarterly	quarterly
Sector	Stock	REIT

Year-by-year: RVVTF vs NNN ($10,000, DRIP)

Year	RVVTF Portfolio	RVVTF Income/yr	NNN Portfolio	NNN Income/yr	Gap
1← crossover	$779,931	$769,230.77	$10,735	$614.96	+$769.2K → RVVTF
2	$56,904,315	$56,069,789.30	$11,572	$708.43	+$56.89M → RVVTF
3	$3,884,151,673	$3,823,264,055.84	$12,531	$819.53	+$3884.14M → RVVTF
4	$248,050,254,929	$243,894,212,638.74	$13,633	$952.29	+$248050.24M → RVVTF
5	$14,822,056,221,428	$14,556,642,448,653.80	$14,909	$1,111.84	+$14822056.21M → RVVTF
6	$828,776,618,419,079	$812,917,018,262,150.50	$16,392	$1,304.77	+$828776618.40M → RVVTF
7	$43,367,472,132,823,630	$42,480,681,151,115,220.00	$18,129	$1,539.52	+$43367472132.81M → RVVTF
8	$2,123,871,047,251,591,000	$2,077,467,852,069,469,400.00	$20,173	$1,827.08	+$2123871047251.57M → RVVTF
9	$97,358,102,514,598,310,000	$95,085,560,494,039,100,000.00	$22,597	$2,181.81	+$97358102514598.30M → RVVTF
10	$4,177,739,098,279,589,000,000	$4,073,565,928,588,968,500,000.00	$25,491	$2,622.67	+$4177739098279589.00M → RVVTF

RVVTF vs NNN: Complete Analysis 2026

RVVTF — Stock

Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company offers cannabinoid pharmaceutical portfolio that focuses on rare inflammatory diseases. It is developing Bucillamine, which is in Phase 3 clinical study for the treatment of infectious diseases, including influenza and COVID-19; Psilocybin that is in Phase 1 clinical study for treating methamphetamine use disorder; Psilocin for the treatment of depression, anxiety, bi-polar disorder, bulimia and anorexia nervosa, and other diseases; and cannabidiol for treating autoimmune hepatitis and ischemia and reperfusion injury from organ transplantation. Revive Therapeutics Ltd. has research collaboration agreements with PharmaTher Inc. for the development of psilocybin in the treatment of cancer and the discovery of other uses of undisclosed psychedelic compounds; North Carolina State University for the development of a biosynthetic version of psilocybin based on a natural biosynthesis enzymatic platform; the University of California, San Francisco to explore the use of Bucillamine as a treatment for severe COVID-19; University of Health Sciences Antigua for the clinical research of psychedelics; and PharmaTher for the development of psilocybin microneedle patch. The company was incorporated in 2012 and is headquartered in Toronto, Canada.

Full RVVTF Calculator →

NNN — REIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →

📬

Get this RVVTF vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RVVTF vs SCHD RVVTF vs JEPI RVVTF vs O RVVTF vs KO RVVTF vs MAIN RVVTF vs ADC RVVTF vs EPRT RVVTF vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.